Company 1 identity field
Location
Hackensack, NJ
SEC filing record 1 source field
Fiscal year end
31 December
Protalix BioTherapeutics, Inc. has filed 957 SEC EDGAR filings since 13 Aug 1996

SEC filing history

Showing 1-3 of 3 matching filings.

Per page
25
Current page
1
SC 13D/A File 005-50118

SC 13D/A

Filing date
17 Sep 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-50118

SC 13D/A

Filing date
28 Aug 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-50118

SC 13D/A filing

Filing date
20 Jan 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .